1. Effects of Rosi treatment on ASKO mice.
Effects of Rosi treatment on ASKO mice. Rosi (0.03%) or vehicle was administered to 6-month-old male WT and ASKO mice for 10 weeks. A: Body weight curve (left) and total fat weight (right) of WT and ASKO mice with or without Rosi. B: Fat pad weight of WT and ASKO mice with or without Rosi. C: H&E staining of subcutaneous WAT from WT and ASKO mice with or without Rosi. Arrows indicate putative newly formed adipocytes. Scale bar is 50 µm. D: Expression of PPAR-γ and its target genes in Epi-WAT. E: Weight changes of BAT in WT and ASKO mice with or without Rosi. F: Plasma total cholesterol (TC), TAG, glucose (GLU) (left), and NEFA (right) in mice fasted for 4 h. Plasma glucose concentrations for glucose tolerance tests (GTT) (G) and insulin tolerance tests (ITT) (H) in mice fasted for 16 h and 4 h, respectively. Area under curve (AUC) is also quantified. Plasma levels of insulin (I), leptin, and adiponectin (J) in mice fasted for 4 h. Values are the mean ± SEM, n = 5–8. *P < 0.05, **P < 0.01, ***P < for Rosi diet vs. normal diet (ND). #P < 0.05, ##P < 0.01, ###P < for ASKO vs. WT.
Lu Liu et al. Diabetes 2014;63:
©2014 by American Diabetes Association